BioNTech

The country is emerging as an attractive place for Big Pharma to chase billion-dollar licensing deals

A combination Covid-flu vaccination developed by Pfizer and BioNTech missed on one of its goals in a final-stage trial, a disappointment for the companies trying to make further use of the technology ...

LOSSES at German drugmaker BioNTech quadrupled in the second quarter from a year earlier, the company said on Monday (Aug 5), as it banks on a strategy shift towards new cancer treatments following a ...

GlaxoSmithKline believes its patents “provided the foundational technology used in Pfizer and BioNTech’s Covid-19 mRNA vaccines”

BIONTECH on Tuesday (Jan 9) said it would return to revenue growth in 2025, forecasting that the ongoing decline in its Covid-19 vaccine business would bottom out and that it would also invest to scal...

BRUSSELS is discussing with Pfizer and BioNTech the possibility of reducing the 500 million Covid-19 vaccine doses the European Union (EU) has committed to buy this year in return for a higher price, ...

BioNTech has agreed to acquire British artificial intelligence (AI) startup InstaDeep for up to £562 million (S$909.5 million) to speed up its biotech research and manufacturing capabilities.

CHINA’S Shanghai Fosun Pharmaceutical Group said users of its mobile health app in China can now register to take Covid-19 booster shots in Hong Kong using BioNTech’s vaccine.

One of the pioneers in messenger RNA vaccines sees limits to their effectiveness against cancers, even after a successful trial raised expectations for the technology.